Osage University Partners
SelectiveFiled to raiseBala Cynwyd, PABiotechnology, Healthcare, PharmaceuticalsLast fund filed April 2022
4 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Osage University Partners IV | April 2022 | $275M | $196M | 94 |
| Osage University Partners IIIFiled to raise in 2018, with no closing reported yet. | 2018 | $250M | $0 | 0 |
| Osage University Partners II | September 2014 | $200M | $151M | 145 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Matthew Cohen | Selective | None listed | 10 | 3 |
Classified sectors of Osage University Partners’s own portfolio companies, based on 26 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| OUP | 18 | Atterocor, COLLECTIONS MARKETING CENTER, Embodied, Halfpenny Technologies, Homebase Automation, Hyalex Orthopaedics, MC10, MediSix Therapeutics, MicroTransponder, Neuros Medical, PARACOSM, Pliant.io, PsiKick, Resolve Digital Health, Ribon Therapeutics, Runa, StreetLight Data, TruLite Health |
| U.S Venture Partners | 3 | MicroTransponder, Neuros Medical, Ribon Therapeutics |
| Aperture | 1 | Neuros Medical |
| Marc Singer | Quiet | Data & analytics, Digital health, Manufacturing & industrials | 5 | 0 |
| Robert Adelson | Quiet | Digital health, Enterprise software, Robotics & hardware | 6 | 0 |
| William Harrington | Quiet | Biotech & pharma, Medical devices, Fintech | 7 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Osage University Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Breakthrough Energy Ventures |
| 1 |
| MC10 |
| Calibrate Ventures | 1 | Embodied |
| Lightstone Ventures | 1 | MediSix Therapeutics |
| Material Impact | 1 | MC10 |
| North Bridge Venture Partners | 1 | MC10 |
| Sigma Prime | 1 | Pliant.io |
| Treo Ventures | 1 | Hyalex Orthopaedics |
A shared board seat: a company where filings name a Osage University Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.